Esposito Pamela
SEC insider (Form 3/4/5 filer). CIK 0001744425. Director at Kymera Therapeutics, Inc. (KYMR). 30 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in WATERTOWN, MA.
Companies Esposito Pamela has filed insider reports for
- Kymera Therapeutics, Inc. (KYMR): Director
Esposito Pamela
CIK: 0001744425
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kymera Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Jun 24, 2026KYMR
Kymera Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
6.1K shares- - May 19, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect1K shares at avg. $31.20$31K - Mar 20, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.2K shares at avg. $79.94$96K - Mar 20, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect600 shares at avg. $79.24$48K - Mar 20, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect700 shares at avg. $77.71$54K - Mar 20, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $49.10$123K - Feb 20, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect600 shares at avg. $88.10$53K - Feb 20, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.9K shares at avg. $87.06$165K - Feb 20, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $49.10$123K - Jan 20, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect3K shares at avg. $31.20$94K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 | KYMR Kymera Therapeutics, Inc. | Award Stock Option (Right to Buy) | 6,068 | - | - | Direct |
| May 19, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 1,000 | $31.20 | $31,200 | Direct |
| Mar 20, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,200 | $79.94 | $95,933 | Direct |
| Mar 20, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 600 | $79.24 | $47,546 | Direct |
| Mar 20, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 700 | $77.71 | $54,398 | Direct |
| Mar 20, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 2,500 | $49.10 | $122,750 | Direct |
| Feb 20, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 600 | $88.10 | $52,860 | Direct |
| Feb 20, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,900 | $87.06 | $165,410 | Direct |
| Feb 20, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 2,500 | $49.10 | $122,750 | Direct |
| Jan 20, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 3,000 | $31.20 | $93,600 | Direct |
1-10 of 30 transactions